|
IMNM Immunome Inc 1472012 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-73,127,000.00 |
| Balance Sheet |
|
Current Assets
|
$538,449,000.00 |
|
Assets
|
$565,384,000.00 |
|
Current Liabilities
|
$35,713,000.00 |
|
Liabilities
|
$40,301,000.00 |
|
Equity
|
$525,083,000.00 |
|
Shares Out
|
113399202.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-120,330,000.00 |
|
Investing Cash Flow
|
$-316,369,000.00 |
| Market Analysis |
Market Cap
|
$3,184,249,592.16 |
|
Price
|
$23.97 |
|
BVPS
|
4.63 |
|
PB
|
6.06 |
|
EPS
|
-0.65 |
|
FCF
|
$-125,508,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:20 |
|
| Apr |
May |
Jun |
| 2026-03-03 |
-2.43 |
|
|
2026-05-12 |
-0.48 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-0.50 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.65 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IMNM documents filed with the SEC.
IMNM Filings
Clear
